Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team
PRINCETON, N.J. and SINGAPORE, Feb. 15, 2022 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced significant expansion of the Scientific Advisory Board ("SAB"). The newly appointed members of the Scientific Advisory Board include: Stuart Grossman, MD; William...
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia
BANGKOK, April 4, 2022 /PRNewswire/ -- SeaX Ventures (Southeast Asia Exponential Ventures) announced today the close of its second fund to help accelerate the growth of global startups throughout Southeast Asia. The fund is dedicated to investing in companies working on truly transformational opportunities in sectors including blockchain & web3, foodtech, biotech & life science, artificial intelligence, robotics, and...
Angel Yeast Turns Automation into Opportunity, Ensuring No Job Losses
YICHANG, China, Nov. 15, 2024 /PRNewswire/ -- Angel Yeast has taken a significant step towards modernization and sustainability by automating its packaging line while ensuring no layoffs for its employees. In 2024, with the completion of the intelligent transformation of its packaging workshop, the company launched a comprehensive retraining program at its...
SynbioTech’s TWK10 Approved to Boost Muscle Strength, The Probiotic Pioneer Marches Toward Southeast Asia Market
BANGKOK, Sept. 11, 2025 /PRNewswire/ -- SynbioTech Inc., ranked among the world's top 20 probiotic suppliers, is the leader in functional probiotics for muscle and joint health, sports, women's wellness, and immune support. Its patented flagship probiotic, Lactiplantibacillus plantarum TWK10®, has earned multiple awards in Europe, the US and Japan, with clinical trials showing increased muscle mass and...
Nona Biosciences Appoints Dr. Hongjiang Miao as Chief AI Officer to Advance A³ Strategy and AI-Driven Drug Discovery
CAMBRIDGE, Mass., Dec. 4, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea to IND), today announced the appointment of Dr. Hongjiang Miao as Chief AI Officer. Dr. Miao will be based in Shanghai...
Kexing Biopharm Participates in the 17th Biotech Showcase, with Multiple Innovation Pipelines Gaining Attention
SHENZHEN, China, Jan. 24, 2025 /PRNewswire/ -- From January 13 to 16, Dr. Huiming Li, Deputy General Manager of Kexing Biopharm New Drug Research Center, attended the 17th Biotech Showcase Conference in San Francisco and the Global Biopharma Symposium hosted by Jones Day & MSQ Ventures. The Jones Day & MSQ Ventures Pre-JPM Symposium builds impactful partnerships for top leaders...
FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data CHENGDU, China, Jan. 19, 2026 /PRNewswire/ -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company"), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been granted Regenerative Medicine...
Zepp Health’s Amazfit Unveils Bip 5 Unity: Elevating Health and Style Every Step of the Way
MILPITAS, Calif., May 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, has today announced the availability of the Amazfit Bip 5 Unity. Blending cutting-edge technology with an elegant design, the Amazfit Bip 5 Unity redefines the standard for everyday smartwatches, offering a seamless fusion of style and...
SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma
SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced late-breaking clinical data from its first-in-class autologous hepatitis B virus (HBV)-specific T-cell receptor-engineered T Cell (TCR-T) therapy – SCG101 – at the 2023 AASLD Liver Meeting in Boston, United States. Results from...
NEC Thailand conducts POC for elderly care in preparation for an aging society
BANGKOK, Nov. 9, 2022 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand) has conducted a POC for elderly care in preparation for an aging society. The POC features a range of technological solutions designed to improve elderly care across Asia. The announcement follows a successful month-long trial in June at an elderly care...
